To elucidate the types of voltage-dependent Ca 2+ channels controlling acetylcholine and catecholamine releases in the in vivo adrenal medulla, we implanted microdialysis probes in the left adrenal medulla of anesthetized rats and investigated the effects of Ca did not change acetylcholine release at 2 and 4 Hz, but nifedipine (300 g/kg) inhibited epinephrine release at 4 Hz by 20% and nifedipine (900 g/kg) inhibited norepinephrine and epinephrine releases at 4 Hz by 30%. In conclusion, both N-and P/Q-type Ca 2+ channels control acetylcholine release on pre-ganglionic splanchnic nerve endings while L-type Ca 2+ channels do not. L-type Ca 2+ channels are involved in norepinephrine and epinephrine releases on chromaffin cells.
Introduction

Ca
2+ influx through the voltage-dependent Ca 2+ channels induces the release of transmitters from neuronal or secretory cells by initiating exocytosis from vesicles. Voltagedependent Ca 2+ channels have been classified into L-, N-, P-, Q-, R-, and T-types (12, 25, 30) .
To better understand the mechanism controlling the release of transmitters it is important to determine the type of Ca 2+ channels involved in the release of the transmitters on neuronal or secretory cells.
In the in vivo adrenal medulla, catecholamine release is controlled by central sympathetic neurons through pre-ganglionic splanchnic nerves. Splanchnic nerve endings make synaptic-like contacts with chromaffin cells (9) . Acetylcholine (ACh) released from splanchnic nerve endings consequently evokes catecholamine release from chromaffin cells by activation of cholinergic receptors. Thus, in vivo catecholamine release requires Ca 2+ influx through the voltage-dependent Ca 2+ channels at two different sites in the adrenal medulla: splanchnic nerve endings and chromaffin cells. Numerous studies have investigated the nature of Ca 2+ channels controlling transmitter release from post-ganglionic autonomic nerve endings (8, 11, 32, 33, 36, 37) . Little information is, however, available on the type of Ca 2+ channels controlling the ACh release from pre-ganglionic autonomic nerve endings including splanchnic nerve endings. Moreover, although the types of Ca 2+ channels controlling catecholamine release have been investigated using isolated chromaffin cells in various species (5, 6, 13, 16, 21, 23, 24) , it remains unknown whether endogenous ACh induces Ca 2+ influx through the same types of Ca 2+ channels on chromaffin cells.
We have recently developed a dialysis technique to simultaneously monitor ACh and catecholamine releases in the in vivo adrenal medulla (2) . This method makes it possible to characterize Ca 2+ channels controlling ACh release from splanchnic nerve endings and catecholamine release from adrenal medulla in the in vivo state. In the present study, we
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applied the microdialysis technique to the adrenal medulla of anesthetized rats and investigated the effects of Ca 2+ channel antagonists on dialysate ACh and catecholamine responses induced by the electrical stimulation of splanchnic nerves.
Materials and Methods
Animal preparation
The investigation conforms with the recording heart rate. A thermostatic heating pad was used to keep the esophageal temperature within a range of 37 -38 °C. With the animal in the lateral position, the left adrenal gland and left splanchnic nerve were exposed by a subcostal flank incision, and the left splanchnic nerve was transected. Shielded bipolar stainless steel electrodes were applied to the distal end of the nerve, which was then stimulated with a digital stimulator (SEN-7203, Nihon Kohden, Japan) with a rectangular pulse (10 V and 1 ms in duration).
Dialysis technique
The materials of the dialysis probe were the same as those used in our previous dialysis experiments (1, 2) . Briefly, each end of the dialysis fiber (0.31 mm OD, and 0.20 mm ID; PAN-1200 50,000-mol wt cutoff, Asahi Chemical, Japan) was inserted into the polyethylene tube (25-cm length, 0.5 mm OD, and 0.2 mm ID; SP-8) and glued. The length of
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The left adrenal gland was gently lifted, and the dialysis probe was implanted in the medulla of the left adrenal gland along the long axis by using a fine guiding needle. The dialysis probe was perfused with Ringer's solution containing a cholinesterase inhibitor, neostigmine (10 M) at a speed of 10 l/min using a microinjection pump (CMA/100, Carnegie Medicin, Sweden). Ringer's solution with no buffer consisted of (in mM) 147.0 NaCl, 4.0 KCl, 2.25 CaCl 2 . One sampling period was 2 min (1 sample volume = 20 l). We started the protocols followed by a stabilization period of 3 to 4 hours and sampled dialysate taking the dead space volume into account.
Dialysate ACh, norepinephrine (NE) and epinephrine (Epi) concentrations were measured as indices of ACh and catecholamine releases in the adrenal medulla. Half of the dialysate sample was used for the measurement of ACh, and the remaining half for the measurement of NE and Epi. ACh and catecholamine assays were separately conducted using each high-performance liquid chromatography with electrochemical detection as previously described (3, 4) .
Experimental design
The experiment was performed based on the previous experiment showing that dialysate ACh and catecholamine responses were reproducible on repetition of stimulation (2) . channel antagonists based on the dose used in the earlier experiments (7, 14, 26, 29, 37) and tested -conotoxin GVIA (10 g/kg) in 6 rats, -conotoxin MVIIC (50 g/kg) in 6 rats, and nifedipine (300 g/kg) in 6 rats. Secondly, we tested a 5-fold higher dose of -conotoxin GVIA (50 g/kg) in 6 rats, a combination of 5-fold higher doses of -conotoxin GVIA (50 g/kg) and MVIIC (250 g/kg) in 6 rats, and a 3-fold higher dose of nifedipine (900 g/kg) in 6 rats. We did not test a higher dose of -conotoxin MVIIC singly because a high dose ofconotoxin MVIIC loses its selectivity for P/Q-type and inhibits N-type Ca 2+ channels (18) .
Nifedipine was administered twice before 2 and 4 Hz-stimulation, but -conotoxin GVIA and MVIIC were administered once before 2 Hz-stimulation because -conotoxin family have long-lasting blocking actions (8, 18, 36) . We assessed the responses to nerve stimulation 30, 20, and 10 min after administration of -conotoxin GVIA, -conotoxin MVIIC, and nifedipine, respectively, when heart rate and arterial pressure had already been stabilized.
At the end of the experiment the rats were sacrificed with pentobarbital sodium, and the implant sites were examined. The dialysis probes were confirmed to have been implanted in the adrenal medulla, and no bleeding or necrosis was found macroscopically.
Drugs
Drugs were mixed fresh for each experiment. Neostigmine methylsulfate (Shionogi, Japan), -conotoxin GVIA (Peptide Institute, Japan), -conotoxin MVIIC (Peptide Institute) were dissolved and diluted in Ringer's solution. Nifedipine (Sigma Chemical, USA) was dissolved in ethanol and diluted in Ringer's solution.
Statistical methods
To examine the effects of nerve stimulation and Ca 2+ channel antagonists, we analyzed heart rate and mean arterial pressure, and dialysate ACh, NE and Epi responses, by using one way analysis of variance with repeated measures. When statistical significance was
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detected, the Newman-Keuls test was applied (35) . Statistical significance was defined as P < 0.05. Values are presented as means ± SE.
Results
Effects of Ca
2+ channel antagonists on heart rate and mean arterial pressure -Conotoxin GVIA (10 g/kg) decreased heart rate from 418 ± 9 to 328 ± 13 beats/min (P < 0.05) and mean arterial pressure from 115 ± 2 to 74 ± 2 mmHg (P < 0.05). -Conotoxin GVIA (50 g/kg) did not further decrease heart rate and mean arterial pressure. -Conotoxin MVIIC decreased heart rate from 408 ± 3 to 390 ± 5 beats/min (P < 0.05) but did not change mean arterial pressure. Combined -conotoxin GVIA and MVIIC decreased heart rate from 415 ± 10 to 327 ± 4 beats/min (P < 0.05) and mean arterial pressure from 124 ± 2 to 57 ± 2 mmHg (P < 0.05). Nifedipine (300 g/kg) decreased mean arterial pressure from 113 ± 4 to 86 ± 4 mmHg (P < 0.05), but did not change heart rate. Nifedipine (900 g/kg) decreased mean arterial pressure from 124 ± 3 to 73 ± 2 mmHg (P < 0.05). Effects of -conotoxin GVIA ( Fig. 1) : -Conotoxin GVIA (10 g/kg) significantly inhibited ACh release at 2 Hz from 6.2 ± 0.9 to 3.6 ± 0.5 nM, ACh release at 4 Hz from 12.2 ± 1.7 to 7.9 ± 1.2 nM, NE release at 4 Hz from 34 ± 6 to 17 ± 3 nM, Epi release at 2Hz from 81 ± 13 Hz from 88 ± 9 to 13 ± 3 nM, and Epi release at 4 Hz from 187 ± 20 to 49 ± 9 nM.
Effects of nifedipine (Fig. 4) : Nifedipine (300 g/kg) did not change ACh release at either frequency, but significantly inhibited Epi release at 4 Hz from 172 ± 31 to 135 ± 23 nM.
Inhibitions of Epi release at 2 Hz and NE release at either frequency were not statistically significant. A 3-fold higher dose of nifedipine (900 g/kg) did not change ACh release, but significantly inhibited Epi release at 4 Hz from 188 ± 24 to 128 ± 15 nM and NE release at 4
Hz from 33 ± 5 to 24 ± 4 nM. Inhibitions of NE and Epi releases at 2 Hz were not statistically significant.
Discussion
Effects of Ca 2+ channel antagonists on ACh release from splanchnic nerve endings
In the present study, -conotoxin GVIA (10 g/kg) inhibited ACh release at both 2 In isolated rat adrenal glands, catecholamine release induced by field stimulation is sensitive to P/Q-type Ca 2+ channel antagonist, whereas that induced by exogenous ACh is insensitive (27) . This indirect study suggested the involvement of P/Q-type Ca 2+ channels in ACh release, but failed to show the involvement of N-type Ca 2+ channels. In isolated bovine adrenal glands, a direct measurement study showed that a reduction of the extracellular Ca 2+ concentration inhibits 3 H-labelled ACh release induced by field stimulation but N-and L-type Ca 2+ channel antagonists do not (28) . Thus, our findings are in part consistent with these direct and indirect studies, but inconsistent as to the involvement of N-type Ca 2+ channels.
This discrepancy might be ascribed to the experimental method. The contribution of Ca 2+ channels may vary with the type of method used to evoke ACh release. In these studies, ACh release was evoked by electrical field stimulation of isolated adrenal glands, which is known to induce ACh release but not direct depolarization of chromaffin cells (34) . In the present study, ACh release was evoked in the in vivo state by electrical stimulation of splanchnic nerves. The type of Ca 2+ channels involved in ACh release may vary with the frequency, amplitude or time period of stimulation. Actually, in the present study, we observed
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The time period of 2 min in the present study seems to be longer than those in earlier studies but could be within the physiological range. Moreover, the blocking action of -conotoxin GVIA is time-dependent as well as dose-dependent and irreversible (8, 11, 32, 36) . The maximum functional effect of -conotoxin GVIA has been observed to be at least 15 min after administration. We evaluated the effect of -conotoxin GVIA 30 min after intravenous administration, when heart rate and mean arterial pressure had already been stabilized. The evaluation early after administration might lead to underestimation of the inhibitory effects of -conotoxin GVIA.
There are many similarities between synaptic transmission from splanchnic nerves to chromaffin cells and sympathetic ganglionic transmission (17) . In isolated guinea-pig paravertebral ganglia, an electrophysiological study has shown that both N-and P-type Ca 2+ channel antagonists reduce cholinergic synaptic conductance, whereas L-type Ca 2+ channel antagonist does not (19) . In isolated rat superior cervical ganglia, both N-and P-type Ca 2+ channel antagonists inhibit the rise in Ca 2+ concentration in the terminal boutons (22) .
Moreover, in isolated rat superior cervical ganglia, 3 H-labelled ACh release induced by high K + is inhibited by both N-and P-type Ca 2+ channel antagonists, but unaffected by L-type Ca 2+ channel antagonist (15) . Our findings are similar to these findings obtained from isolated sympathetic pre-ganglionic nerves.
The inhibition by -conotoxin GVIA (50 g/kg) was almost same with that byconotoxin GVIA (10 g/kg). Moreover, the inhibition by combined -conotoxin GVIA (50 g/kg) and MVIIC (250 g/kg) was almost algebraically the sum of the individual inhibition by -conotoxin GVIA (10 g/kg) and MVIIC (50 g/kg). These results suggest that 5-fold
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higher doses of -conotoxin GVIA and MVIIC are sufficient to cause inhibition of Ca 2+ channels. But, about 30% of ACh release were resistant to combined -conotoxin GVIA (50 g/kg) and MVIIC (250 g/kg). Other types of Ca 2+ channels except for N-and P/Q-types may be involved in ACh release from splanchnic nerve endings. Further examination could be needed. antagonists inhibit ACh release. Thus, although much of these inhibitions of catecholamine release may be considered to be consequences of the inhibition of ACh release, we can not exclude the possibility that N-or P/Q-type Ca 2+ channels may be involved in the in vivo catecholamine release on chromaffin cells.
Effects of Ca
The inhibition of NE release at 2 Hz by -conotoxin GVIA (10 and 50 g/kg) and the inhibition of NE release at 4Hz by -conotoxin MVIIC (50 g/kg) were not statistically significant in spite of significant inhibitions of ACh and Epi releases. In the same preparation,
we have shown that cholinergic antagonists inhibited almost NE and Epi releases induced by nerve stimulation (1, 2) . But the correlation between ACh and NE releases was poorer than that between ACh and Epi releases when stimulation frequency was raised stepwise (2).
Insignificant inhibitions of NE release may be ascribed to this poor correlation.
In the present study, Ca 2+ channel antagonists did not affect basal dialysate NE and Epi levels. In our previous study of the same preparation, these basal levels were not affected by neostigmine, hexamethonium, or atropine (1). Then, we concluded that these basal dialysate NE and Epi levels reflect non-cholinergic catecholamine release. N-, P/Q-, and Ltype Ca 2+ channels may not play a major role in basal non-cholinergic catecholamine release from adrenal medulla.
Methodological considerations
We administered neostigmine locally to adrenal medulla through a dialysis probe.
Cholinesterase inhibitor was necessary to monitor endogenous ACh even during splanchnic nerve stimulation because released ACh is rapidly degraded by acetylcholinesterase before reaching the dialysis fiber. In the same preparation, local administration of neostigmine Intravenous administration of Ca 2+ channel antagonists induced changes in heart rate or mean arterial pressure. These changes might affect ACh and catecholamine releases through a baroreflex mechanism. Moreover, these hemodynamic changes might decrease the spillover of ACh or catecholamine from adrenal medulla and affect the dialysate ACh or catecholamine concentrations (20) . In our preparation, however, splanchnic nerves had been transected before control sampling, and basal dialysate catecholamine concentrations did not change before or after administration. Thus, effects of these hemodynamic changes could be negligible when we considered the effects of Ca 2+ channel antagonists on nerve stimulationinduced dialysate responses.
Conclusion
We applied dialysis technique to the adrenal medulla of anesthetized rats and investigated the effects of Ca 2+ channel antagonists on ACh and catecholamine releases induced by electrical stimulation of splanchnic nerves. Both N-and P/Q-type Ca 2+ channels control acetylcholine release on pre-ganglionic splanchnic nerve endings while L-type Ca Epi release at 4 Hz (upper panel). Nifedipine (900 g/kg) did not change ACh release at either frequency, but inhibited NE and Epi releases at 4Hz (lower panel). Values are means ± SE from 6 rats. *P < 0.05 vs. ACh, NE, or Epi release at same frequency before administration.
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Figure 1 
